Clinical Trial Update: Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

View source ↗

Summary

Completed clinical trial evaluating ex-vivo hypothermic, oxygenated machine perfusion of donor livers in hepatocellular carcinoma patients undergoing transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Liver Carcinoma, Liver Transplant | Status: COMPLETED